Cargando…

Effect of atorvastatin in patients with chronic heart failure – insights from randomized clinical trials

INTRODUCTION: Recent large clinical trials have yielded disappointing results of rosuvastatin in the chronic heart failure (CHF) population. The question that remains is whether these results of rosuvastatin studies could be extended to other statins. Therefore, we performed a meta-analysis based on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Minwen, Yuan, Gaohui, Wei, Fanping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2010
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302697/ https://www.ncbi.nlm.nih.gov/pubmed/22427759 http://dx.doi.org/10.5114/aoms.2010.19293

Ejemplares similares

Synergistic Effect of Atorvastatin and Folic Acid on Cardiac Function and Ventricular Remodeling in Chronic Heart Failure Patients with Hyperhomocysteinemia
por: Peng, You, et al.
Publicado: (2018)

Effect of CETP Polymorphism on Atorvastatin Lipid-Regulating Effect and Clinical Prognosis of Patients with Coronary Heart Disease
por: Gu, Guo-Long, et al.
Publicado: (2014)

Percutaneous renal artery denervation in patients with chronic systolic heart failure: A randomized controlled trial
por: Gao, Jun-Qing, et al.
Publicado: (2019)

Effect of atorvastatin on serum periostin and blood eosinophils in asthma – a placebo-controlled randomized clinical trial
por: Mehrabi, Samrad, et al.
Publicado: (2021)

Combination of atorvastatin/coenzyme Q10 as adjunctive treatment in congestive heart failure: A double-blind randomized placebo-controlled clinical trial
por: Pourmoghaddas, Masoud, et al.
Publicado: (2014)

Treatment with atorvastatin is associated with a better prognosis in chronic heart failure with systolic dysfunction: results from The Daunia Heart Failure Registry
por: Correale, M., et al.
Publicado: (2013)

Effect of atorvastatin on iron metabolism regulation in patients with chronic kidney disease – a randomized double blind crossover study
por: Masajtis-Zagajewska, Anna, et al.
Publicado: (2018)

Effect of ATorvastatin On Chronic subdural Hematoma (ATOCH): a study protocol for a randomized controlled trial
por: Jiang, Rongcai, et al.
Publicado: (2015)

An open label randomized controlled trial of atorvastatin versus aspirin in elite controllers and antiretroviral-treated people with HIV
por: Mystakelis, Harry A., et al.
Publicado: (2023)

Efficacy and safety of Zhibitai in combination with atorvastatin for lipid lowering in patients with coronary heart disease
por: Xu, Danyan, et al.
Publicado: (2017)

Tolerability and effectiveness of every-other-day atorvastatin compared to daily atorvastatin in patients with muscle symptoms: A randomized controlled clinical trial
por: Wijekoon, Nirmala, et al.
Publicado: (2020)

Therapeutic effects of atorvastatin and ezetimibe compared with double-dose atorvastatin in very elderly patients with acute coronary syndrome
por: Liu, Zhi, et al.
Publicado: (2017)

Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: assessment of clinical usefulness in CKD patients with atorvastatin (ASUCA) trial
por: Kimura, Genjiro, et al.
Publicado: (2016)

Pulmonary function differences in patients with chronic right heart failure secondary to pulmonary arterial hypertension and chronic left heart failure
por: Liu, Wei-Hua, et al.
Publicado: (2014)

The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart ‘OMics’ in AGEing (HOMAGE) randomized clinical trial
por: Cleland, John G F, et al.
Publicado: (2020)

Quality of life in heart failure patients undergoing hybrid comprehensive telerehabilitation versus usual care – results of the Telerehabilitation in Heart Failure Patients (TELEREH-HF) Randomized Clinical Trial
por: Piotrowicz, Ewa, et al.
Publicado: (2020)

Effects of Atorvastatin on Negative Sign in Chronic Schizophrenia: a Double Blind Clinical Trial
por: Sayyah, Mehdi, et al.
Publicado: (2015)

Sodium restriction in patients with chronic heart failure and reduced ejection fraction: A randomized controlled trial
por: Ivey-Miranda, Juan B., et al.
Publicado: (2022)

Effect of melatonin supplementation on endothelial function in heart failure with reduced ejection fraction: A randomized, double‐blinded clinical trial
por: Hoseini, Shervin Ghaffari, et al.
Publicado: (2021)

Atorvastatin for Prevention of Amikacin-induced Electrolytes Imbalances; a Randomized Clinical Trial
por: Heydari, Behrooz, et al.
Publicado: (2016)

Impact of COVID-19 on Heart Failure Clinical Trials: Insights From the Heart Failure Collaboratory
por: Bhatt, Ankeet S., et al.
Publicado: (2023)

Effect of coenzyme Q(10) in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial
por: Mortensen, Anne Louise, et al.
Publicado: (2019)

Atorvastatin combined with dexamethasone in chronic subdural haematoma (ATOCH II): study protocol for a randomized controlled trial
por: Jiang, Rong Cai, et al.
Publicado: (2021)

Effects of Atorvastatin in Patients with Acute Spinal Cord Injury
por: Aghazadeh, Javad, et al.
Publicado: (2017)

Dronedarone in patients with congestive heart failure: insights from ATHENA
por: Hohnloser, Stefan H., et al.
Publicado: (2010)

Mode of death in elderly and super‐elderly patients with acute heart failure: Insights from Japanese heart failure registry
por: Takabayashi, Kensuke, et al.
Publicado: (2021)

Patient recruitment to a randomized clinical trial of behavioral therapy for chronic heart failure
por: Chang, Bei-Hung, et al.
Publicado: (2004)

Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: the supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial
por: Sakata, Yasuhiko, et al.
Publicado: (2015)

Evaluation of the Anti-inflammatory Effects of Atorvastatin on Patients with Rheumatoid Arthritis: A Randomized Clinical Trial
por: Sarabi, Zhaleh Shariati, et al.
Publicado: (2016)

Evaluation of Atorvastatin for the Treatment of Patients With Asthma: A Double-Blind Randomized Clinical Trial
por: Moini, Abdollatif, et al.
Publicado: (2012)

Atorvastatin for patients with cirrhosis. A randomized, placebo-controlled trial
por: Kronborg, Thit M., et al.
Publicado: (2023)

Vitamin D Levels and Lipid Response to Atorvastatin
por: Pérez-Castrillón, José Luis, et al.
Publicado: (2010)

Effect of remote monitoring on clinical outcomes in European heart failure patients with an implantable cardioverter-defibrillator: secondary results of the REMOTE-CIED randomized trial
por: Chiu, Cheyenne S L, et al.
Publicado: (2021)

Effect of atorvastatin treatment on circulating adiponectin: a meta-analysis of randomized controlled trials
por: Liu, Xiaoyu, et al.
Publicado: (2019)

The effects of atorvastatin on mustard-gas-exposed patients with chronic obstructive pulmonary disease: A randomized controlled trial
por: Ghobadi, Hassan, et al.
Publicado: (2014)

Effect of an orientation group for patients with chronic heart failure: randomized controlled trial
por: Arruda, Cristina Silva, et al.
Publicado: (2018)

Safety of atorvastatin in Asian patients within clinical trials
por: Chan, Juliana C. N., et al.
Publicado: (2016)

New insights into the pathogenesis and treatment of sarcopenia in chronic heart failure
por: Yin, Jiayu, et al.
Publicado: (2019)

A clinical randomized trial on the use of atorvastatin in patients with sepsis or septic shock: effects on endothelial function
por: Prado, K, et al.
Publicado: (2013)

Identifying the causal relationship between sedentary behavior and heart failure: Insights from a Mendelian randomization study and mediation analysis
por: Zheng, Xifeng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4rm5d9j9436grtrq3nfhi8osoc